Ahad Khoshzaban1,2,3, Peyman Keyhanvar2, Elham Delrish2, Farhood Najafi4, Saeed Heidari Keshel2, Ikuya Watanabe5, Alireza Valanezhad5, Tahereh Jafarzadeh Kashi1,6. 1. Iranian Tissue Bank and Research Center, Imam Khomeini Medical Complex Hospital, Tehran University of Medical Sciences, Tehran, Iran. 2. Stem Cell Preparation Unit, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran. 3. Department of Dental Biomaterials, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran. 4. Department of Resin and Additives, Institute for Color Science and Technology, Tehran, Iran. 5. Department of Bio-Engineering, Nagasaki University, Nagasaki, Japan. 6. Department of Dental Biomaterials, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran.Electronic Address: jafarzat@tums.ac.ir.
Alginate is a popular group of anionic polysaccharides
extracted from seaweeds (1, 2) that could be produced
by some brown algae and certain bacteria species such
as Azotobacter vinelandii and Pseudomonas aeruginosa
(2). Also, alginate has different applications and could
be found in nature in the forms heteropolysaccharide
hydrogel of ß-D-mannuronate and a-L-guluronate,
physically cross-linked with divalent ions such as calcium
to form an anionic hydrogel (1, 3, 4). The simple, mild
aqueous-based gel formation of sodium alginate in the
presence of divalent cations is suitable for encapsulation
of various drugs with different properties (3).The scaffold usage is justified as it provides a suitable
headstock for cell growth, proliferation and differentiation
(2). In vitro and in vivo studies revealed that no scaffold
can guarantee long-term viability of cells. Because of
biocompatible, non-toxic and non-immunogenic properties
of alginate, it is used as a common scaffold which functions
both as a cytokines carrier and scaffold (4). In addition, it
can be used in capsule form as a carrier of the stem cells
(3). One of the applications of this material is protection
of stem cells from immune responses (4). Therefore, the
nutrient release and cytokines properties of alginate can
be influenced its clinical application particularly in bone
tissue engineering and vascularization (2, 3).Alginate microcapsules (AM) can be saturated with
different solutions (3) and they may have direct effects on
cells. It is reported that AM helps the smart differentiation
of stem cells and induced pluripotent stem (IPS) cells.
It is reported that alginate can be used for stem cells
encapsulation (5).The microcapsules have disadvantages such as being
easily ruptured as they possess low micromechanical
properties. Up to the present, several studies have been
done on application of different materials or changing
the synthesis protocols to improve the micromechanical
properties of AM (4). For instance, CaCl2-anionic
hydrogel-chitosan, G (a-L-guluronic acid) and M
(ß-D-mannuronic acid) were used to enhance the
micromechanical properties of AM (1, 3).The molecular composition of alginates depends on the
organism and isolated tissue by which the alginate has
been produced (3). Alginates prepared from the stipes of
old L. Hyperborea kelp contain the highest content of a-Lguluronic
acid residues while alginate from Ascophyllum
nodosumand Lonicera japonica, has lower amounts
of a-L-guluronic acid (6). It is revealed that alginate is
not subjected to a regular repeatability according to
Bernoullian statistics (i.e. the units of alginate are found
in a separate chain and it has monomers along) (3). In cell
therapy, the optimum time within which cells should be
viable is at least 72 hours and alginate is expected to have
the capacity of maintaining cell viability for this period (7).
In most studies, AM is used for stem cell maintenance and
differentiation (5-7). Also, alginate hydrogel accelerates
wound healing process and prevents infection (8).According to AM medical activity or alginate hydrogel,
the supply of nutrient solution has been used in cell culture
(8). Nutrients (cell culture media) have been frequently
used in cell culture but clinical investigations indicated
that cells injection might not work in the absence of
nutrients (7). The main objective of the present study is
application of microcapsules as suppliers of nutrients
for growth and proliferation of cells in comparison with
conventional culture method.
Materials and Methods
Alginate microcapsules synthesis
In this experimental study, sodium alginate, potassium
and calcium chlorides were procured from Sigma
Aldrich, UK. The chemicals were used without further
purification. The particle size and surface morphology of
the microcapsules were examined by Scanning Electron
Microscopy (SEM) (Fig .1A, B).
Fig.1
Alginate microcapsule (AM) scanning electronic and microscopic views. A. Two AM in scanning electron microscopy (SEM) view (×70), B. AM view
in SEM view (20 KV), and C. One microcapsule under invert microscope (×40).
Fabrication of microspheres
The AM were typically synthesized as previously
described (6). A total of 3.1 g of alginate was added to 100
mL of distilled water and the resultant mixture was stirred
until the alginate was completely dissolved. Afterward,
the alginate solution was filtered and passed through
a syringe pump to form droplets. Then, it was dropped
at 5 mL/hour through a flat 25G5/8 sterile needle into a
crosslinking bath containing 0.1 M calcium chloride to
produce calcium alginate microspheres (6-8). To reduce
droplets size, airflow of 12.5 L/minute through 3 mm
tube was used over the needle. The alginate droplets
were transformed to alginate beads by gelling in a 100
mM CaCl2 solution (containing 2 mM KCl) for at least
10 minutes. Subsequently, the beads were washed three
times in Ca2+-, Mg2+-free solution (GibcoBRL) (pH=7.0)
containing 150 mM of NaCl (Merelbeke, Belgium).
The capsules were suspended for another 3 minutes in a
0.3% solution of alginate. As a result, the capsules had a
diameter of 300 µm (Fig .1A).
Particle size test
For selection of the best size of microcapsules,
diffraction particle size analyzer (0.03-1000 µm) SALD2201
laser (Shimadzu, Japan) was used. According to
ISO 13320 (9) and USP (10), this method is suitable for
micron-sized polymer capsules such as alginate. The
obtained graph showed size variation and filtration which
was used to select the best size.
Nutrient load in the microcapsules
After synthesis of microcapsules, they were
transferred and pictures were taken under inverted
florescent microscope (CTI, Spain) (Fig .1C). Then,
10 µL of the nutrient media containing DMEM low
glucose (Gibco, USA) and 10% fetal bovine serum
(FBS, Gibco, USA) was loaded by super fine needles
(Aesculap, Germany) (Fig .2).
Fig.2
Injection media into microcapsules. A. Penetration of needle (32 G)
in alginate microcapsule (AM), B. Filling procedure, and C. AM filled with
nutrient (DMEM).
Alginate microcapsule (AM) scanning electronic and microscopic views. A. Two AM in scanning electron microscopy (SEM) view (×70), B. AM view
in SEM view (20 KV), and C. One microcapsule under invert microscope (×40).Injection media into microcapsules. A. Penetration of needle (32 G)
in alginate microcapsule (AM), B. Filling procedure, and C. AM filled with
nutrient (DMEM).
Releasing test
Micro-capsules were weighed before and after injection
of cell culture media (on day 1, 2 and 10). Microcapsules’
weight was equivalent to the weight of the empty
microcapsules on day 10.
Adipose-derived mesenchymal stem cell isolation,
identification and culture
Adipose-derived mesenchymal stem cells (ADSCs)
were isolated by enzymatic digestion according to Park
AM protocol. Briefly, lipoaspirate tissues (25 ml) were
taken from two volunteers and washed with PBS in a 50ml
Falcon tube. The tissues were then digested with an
equal volume of 0.2% collagenase type IV at 37°C for
15 minutes, and the stromal vascular fraction cells were
isolated by centrifugation at 300 g at room temperature.
Viable cells (1×106) were cultured in 75-cm2 flasks
in 10% FBS-supplemented medium (DMEM/F 12).
After 2 days, the unattached cells were discarded by
replacing the medium with fresh medium. The medium
was subsequently changed twice a week. At 80 to 90%
confluence, both types of cells were harvested with trypsin-
ethylene diamine tetra acetic acid (EDTA, Gibco, UK)
and subsequently replated at 2000 cells/cm2. For analysis
of surface markers expression, at passage 3, AMSCs were
washed three times with phosphate-buffered saline (PBS),
then incubated with a blocking solution of 3% serum in
PBS for 30 minutes. After centrifugation, 5×105 cells
were suspended in blocking solution, then incubated with
antibodies against humanCD31, CD166, CD90, CD44,
CD73, CD34 and CD 45 (Abcam, UK). After incubation
for 30 minutes, the cells were washed with PBS, then
analysis was made by using FACSCalibur flow cytometer
(Becton Dickinson, San Jose, CA, USA) according to the
standard procedures (Figes.3, 4).
Fig.3
DAPI staining cells at different time points in 4 groups. In groups B
and C dark fields were observed after 72 hours and 7 days (CTI Microscope,
Spain, ×20).
DAPI staining cells at different time points in 4 groups. In groups B
and C dark fields were observed after 72 hours and 7 days (CTI Microscope,
Spain, ×20).Adipose-derived mesenchymal stem cells flow cytometry.
Viability cells adhering by microcapsules and nutrient
After loading the microcapsules, the experimental
cells (Human Adipose-Derived Mesenchymal Stem
Cells, AMS) were used in Stem Cell Preparation Unit
Lab, Farabi Eye Hospital, Tehran, Iran. All information
concerning this cell line was recorded in Farabi Eye
Hospital.
Experimental and control groups
The cells were cultured 96-well plates (Falcon, USA), at
the volume of 40 µl. Four experimental groups were used
to determine the role of AM in cell contact and viability
in cell therapy as compared to nutrient media. Group
A (positive control): AMS cells treated with standard
nutrient media 40 µl+20 µl [DMEM low glucose and 10%
FBS Gibco, USA]. Group B (experimental control): AMS
cells (40 µl) with Ringer’s serum (20 µl, Razi Co, Iran).
Group C: AMS cells (40 µl) with empty AM+Ringer’s
serum. Group D: AMS cells (40 µl) with AM+standard
nutrient media+Ringer’s serum (20 µl).
MTT analysis
Viability of AMSCs grown on AM was assessed
by using 3,4,5 dimethylyhiazol-2yl-2-5 diphenyl
tetrazolium bromide (MTT) assay according to the
protocol of MTT. Cells that were grown in normal media
without AM served as a control for the interpretation
of data. Then, 4 wells were selected from 96 wells for
each group. Totally from 4 groups, 16 wells were filled.
For each group 20 µl of MTT solution was added, then
the plates were transferred to a CO2 incubator (Sanyo,
Japan). After 4 hours, the liquid was removed and 100
µl dimethyl sulfoxide (DMSO) was added. Finally,
each of 96-well was transferred to the ELISA reader
(Bio-Rad, USA). Then, the plates were read at 570 nm
and the reference optical density (OD) was 600 nm.
For each plate, MTT assay was done at 24, 48, and 72
hours and on day 7.
DAPI staining
The DAPI assay was done based on the following steps.
4’, 6’ diamino-2-phenylindole 2HCl was used for specific
staining at pH=7. In order to stain, each well was fixed
using 60 µL paraformaldehyde (PFA) 4% for 8 minutes.
The PFA should be dumped onto paper towels and
wrapped in aluminum foils before disposal. Then, cells
were washed with 60 µL/well of 1X PBS, for 3 times
each time for 5 minutes. Cells were mobilized using 60
µL/well of 0.1% Triton-X-100 for 10 minutes and this
process was repeated for 3 times. Cells were stained with
50 µL/well of DAPI (1:2000 dilution, in 1X TBST) for 5
minutes and 50 µL/well of 1X PBS was added to keep the
cells hydrated while imaging on the Image Express Micro
(Fig .3).
Statistical analysis
The results are presented as mean ± SD. The statistical
differences were analyzed by one -way ANOVA followed
by Dunnett’s tests. A P<0.05 was considered to be
significant. All assays were performed in quadruplicate.
Results
Group A had a cell viability of 95% ± 3 at 24, 48,
and 72 hours and on day 7. In groups B and C, after 24
hours, the number of viable cells reduced; therefor, after
day 7, particularly viable cells were not seen (viable
cells or carcass were 0% ± 3). Group D showed the
same results as group A. Accordingly, there were no
significant differences between groups A and D (P>0.05).
A significant difference was observed in groups B and C
compared to group D (P<0.05, Fig .5).
Fig.5
MTT Assay results for each group (4 wells per group). Group B and C
had no viable cells after 7 days.
MTT Assay results for each group (4 wells per group). Group B and C
had no viable cells after 7 days.
Particle size analysis
Microcapsules within the size range of 300-350 µm were
selected and used as the maximum size of microcapsules
(Fig .6A).
Fig.6
Diagrams of particle size and releasing time of microcapsules. A.
Microcapsules particle size and B. Linear diagram of alginate microcapsules
releasing time.
According to our data, the cells in groups A and D
were stained the same at 24, 48, 72 hours and on day 7
with high viability. Accordingly, groups B and C did not
differ significantly and showed less viability than that
of groups A and D particularly after 24 hours. However,
considerable differences were detected at 72 hours and on
day 7 day (Fig .4).The reliable time was in day 7, on which the media was
totally released (Fig .6B).Diagrams of particle size and releasing time of microcapsules. A.
Microcapsules particle size and B. Linear diagram of alginate microcapsules
releasing time.
Discussion
In several studies, AM have been used as a supplier of
nutrients for human fatty-derived mesenchymal stem cells.
Alginates are polyanionic copolymers which have ionic
interactions between the guluronic acid groups (6-9). The
standard and effective substrate used for cell growth in
cell culture is DMEM which is widely used for the growth
of different mammalian cells (7). On the basis of different
reports, many cells such as primary fibroblasts, neurons,
glial cells, HUVECs and smooth muscle cells, as well
as cell lines like HeLa, 293, and Cos-7 were effectively
cultured in DMEM (8).DMEM was originally formulated with low glucose
(1 g/L) and sodium pyruvate, but it is often used with
higher glucose levels, with or without sodium pyruvate
for cell differentiation. Gibco DMEM with GlutaMAX™
supplement minimizes toxic ammonia buildup and
improves cell viability and growth (10-12). Sodium
alginate is biologically safe and widely used in drug
delivery systems (11). It is used to encapsulate various
drugs in alginate beads (13, 14) and to belay matrix beads
(15, 16). Controlling the release of dosage maintains a
consistent therapeutic level of drug and minimizes the
adverse effects. This is suitable for drug therapy as it can
prolong the release of the drug over an extended period,
reduce the frequency of administration, and increase
patient compliance (17, 18).Moshaverinia et al. (19) used the injectable oxidized
alginate micro beads which encapsulated periodontal
ligament (PDL) and gingival mesenchymal stem cells.
As observed in the current study, AM were filled with
DMEM using very fine needles. Then, they were added
to mesenchymal stem cells. The null hypothesis was
that MA might release nutritional media into cell
environment and maintain the viability of stem cells
for a short or long period. In the present research,
MTT assay and DAPI staining were used to monitor
adipose-derived mesenchymal stem cells (ADSCs) cell
culturing. According to our data, similar results were
detected in groups A and D. However, cells in groups B
and C were visible after 24, 48, and 72 hours and after
7 days. The findings of the current study can be used
as the basic information which can open a new window
for alginate usage.There is an increasing interest in microcapsules due to
their wide applications in biomedicine (20), bioreactors,
therapeutics, drug delivery system and tissue engineering
(21). Among several materials available for production of
microcapsules, the most commonly used microsphere is
alginate (19, 22). Researchers have focused on stimuli-
responsive polymeric-hydrogels using alginate due to
its potential applications in drug delivery systems and
tissue engineering (23-27). Lindenhayn et al. (28) used
AM for cartilage tissue engineering and it was detected
that AM protect stem cells. This effect is mediated by
double-membrane microcapsules with a multi-enzyme
system through self-assembly and bio-mineralized
properties (26-29).In the present study, AM (beads) were prepared as
a reservoir containing nutrient media (DMEM) which
was injected to AM. This method is noble and may be
applicable in in vitro and in vivo studies or in clinical trials
of cell therapy. The MTT and DAPI results showed that
AM containing DMEM could support the cells for 7 days.
The obtained results can be used as basic information
and future studies should be conducted to find direct
and cellular mechanism(s) underlying the protective
properties of AM on stem cells. Perhaps this technique
can improve cell culture and cell therapy to be ultimately
used in animal studies or clinical trials.
Conclusion
This achievement may open new horizons and
create new approach for cell viability maintained on
new condition of cell/stem cell culturing media (AM/
media) with sustain release and good biocompatibility
manner without refeeding consecutive. This may lead to
protraction of cell viability on scaffold either in animals
or humans body. The fruition of this survey can play
vital role in the application of AM in tissue engineering
and acts as a supplementary factor for nutrition 72 hours
after implantation of scaffolds with cells in body. It can
also be used as nutrient reservoir or nutrient pump or the
carrier for cell differentiation cytokine in modern applied
techniques. Briefly, nutrition media release of AM showed
effective results. This study can create a new approach on
the application of the AM in tissue engineering and cell
transporting in animal or clinical trials.
Authors: Alireza Moshaverinia; Chider Chen; Kentaro Akiyama; Sahar Ansari; Xingtian Xu; Winston W Chee; Scott R Schricker; Songtao Shi Journal: J Mater Sci Mater Med Date: 2012-09-04 Impact factor: 3.896